Halberd (Halberd) Price-to-Tangible-Book : (As of Jun. 17, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Halberd Price-to-Tangible-Book?

As of today (2024-06-17), Halberd's share price is $0.0087. Halberd's Tangible Book per Share of Jul. 2023 for the quarter that ended in Jul. 2023 was $-0.00. Hence, Halberd's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Halberd's Price-to-Tangible-Book or its related term are showing as below:

HALB's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.72
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Halberd's share price is $0.0087. Halberd's Book Value per Sharefor the quarter that ended in Jul. 2023 was $-0.00. Hence, Halberd's P/B Ratio of today is .

Halberd Price-to-Tangible-Book Historical Data

The historical data trend for Halberd's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Price-to-Tangible-Book Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

Price-to-Tangible-Book

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
Price-to-Tangible-Book	-	-	-

Competitive Comparison of Halberd's Price-to-Tangible-Book

For the Biotechnology subindustry, Halberd's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Halberd's Price-to-Tangible-Book falls into.

Halberd Price-to-Tangible-Book Calculation

Halberd's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jul. 2023 )
	=	0.0087	/	-0.002
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Halberd Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Halberd's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236